Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04838119 · ClinicalTrials.gov registry record

Preop COVID Testing Patterns

A clinical trial, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
375,692
Enrollment target

NCT04838119 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 375,692 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04838119 has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
375,692 participants
Enrollment target

Study Summary

This study is an investigation of preoperative asymptomatic COVID screening nationwide. The hypothesis is that because these tests are performed without reference to pretest probability of COVID-19 disease, unlike tests based on symptoms or close contact with infected individuals, these studies may represent a more unbiased sample of the local population prevalence of asymptomatic COVID disease burden.

Trial Details

FieldValue
Enrollment Target 375,692 participants
Start Date 2021-04-01
Est. Completion 2021-08-23

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT04838119

The ClinicalTrials.gov registry entry for NCT04838119 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 375,692 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT04838119 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04838119 about?

NCT04838119 is a clinical study titled "Preop COVID Testing Patterns". This study is an investigation of preoperative asymptomatic COVID screening nationwide. The hypothesis is that because these tests are performed without reference to pretest probability of COVID-19 disease, unlike tests based on symptoms or close contact with infected individuals, these studies may ...

What is the current status of trial NCT04838119?

This trial is currently completed. The enrollment target is 375,692 participants. The study started on 2021-04-01. Estimated completion is 2021-08-23.

Who is sponsoring clinical trial NCT04838119?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.